Addex Therapeutics Ltd (ADXN) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Addex Therapeutics Ltd (ADXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $7.1M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 2.00 to the broader market. Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Led by Timothy Mark Dyer, public since 2020-02-12.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for ADXN as of 2026-08-23; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →